SEARCH

SEARCH BY CITATION

References

  • 1
    U.S. Centers for Disease Control and Prevention. 2012. National Program of Cancer Registries. United States Cancer Statistics. Available at http://apps.nccd.cdc.gov/uscs/toptencancers.aspx (accessed 18 January 2012).
  • 2
    New York State Cancer Registry. 2011. Cancer incidence and mortality, 2004-2008, New York State. New York State Department of Health. Available at http://www.health.state.ny.us/statistics/cancer/registry/vol1/v1rnys.htm (accessed 28 April 2011).
  • 3
    ASCO. 2011. Progress against colorectal cancer. Available at www.cancerprogress.net (accessed 27 July 2011).
  • 4
    ASCO. 2007. ASCO/NCCN quality measures: breast and colorectal cancers. Available at www.asco.org/qualitymeasures (accessed 28 July 2011).
  • 5
    Desch, C. E., K. K. McNiff, E. C. Schneider, D. Schrag, J. McClure, E. Lepisto, et al. 2008. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J. Clin. Oncol. 26:36313637.
  • 6
    Romanus, D., M. R. Weiser, J. M. Skibber, A. Ter Veer, J. C. Niland, J. L. Wilson, et al. 2009. Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: an NCCN institutional analysis. J. Natl. Compr. Cancer Netw. 7:895904.
  • 7
    Institute of Medicine. 2000. Enhancing data systems to improve the quality of cancer care. National Academies Press, Washington, DC.
  • 8
    Institute of Medicine and National Research Council. 2005. Assessing the quality of cancer care: an approach to measurement in Georgia. National Academies Press, Washington, DC.
  • 9
    Schrag, D., L. D. Cramer, P. B. Bach, and C. B. Begg. 2001. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J. Natl. Cancer Inst. 93:850857.
  • 10
    Kahn, K. L., J. L. Adams, J. C. Weeks, E. A. Chrischilles, D. Schrag, J. Z. Ayanian, et al. 2010. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 303:10371045.
  • 11
    Cooper, G. S., T. D. Kou, and H. L. Reynolds. 2008. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer 113:20292037.
  • 12
    Potosky, A. L., L. C. Harlan, R. S. Kaplan, K. A. Johnson, and C. F. Lynch. 2002. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J. Clin. Oncol. 20:11921202.
  • 13
    Berry, J., L. Caplan, S. Davis, P. Minor, M. Counts-Spriggs, R. Glover, et al. 2010. A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer 116:713722.
  • 14
    Ayanian, J. Z., A. M. Zaslavsky, C. S. Fuchs, E. Guadagnoli, C. M. Creech, R. D. Cress, et al. 2003. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J. Clin. Oncol. 21:12931300.
  • 15
    Bradley, C. J., C. W. Given, B. Dahman, and T. L. Fitzgerald. 2008. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch. Intern. Med. 168:521529.
  • 16
    Cress, R. D., S. A. Sabatino, X. Wu, M. J. Schymura, R. Rycroft, E. Stuckart, et al. 2009. Adjuvant chemotherapy for patients with Stage III colon cancer: results from a CDC-NPCR patterns of care study. Clin. Med. Oncol. 3:107119.
  • 17
    Demissie, K., O. O. Oluwole, B. A. Balasubramanian, O. O. Osinubi, D. August, and G. G. Rhoads. 2004. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between blacks and whites. Ann. Epidemiol. 14:215221.
  • 18
    White, A., C. C. Liu, R. Xia, K. Burau, J. Cormier, W. Chan, et al. 2008. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer 113:34003409.
  • 19
    Roetzheim, R. G., N. Pal, E. C. Gonzalez, J. M. Ferrante, D. J. Van Durme, and J. P. Krischer. 2000. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am. J. Public Health 90:17461754.
  • 20
    Institute of Medicine. 2003. Unequal treatment: confronting racial and ethnic disparities in healthcare. Institute of Medicine of the National Academies Press, Washington, DC.
  • 21
    Boscoe, F. P., D. Schrag, K. Chen, P. J. Roohan, and M. J. Schymura. 2011. Building capacity to assess cancer care in the Medicaid Population in New York State. Health Serv. Res. 46:805820.
  • 22
    Charlson, M. E., P. Pompei, K. I. Ales, and C. R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373383.
  • 23
    Deyo, R. A., D. C. Cherkin, and M. A. Ciol. 1992. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45:6139.
  • 24
    Klabunde, C. N., A. L. Potosky, J. M. Legler, and J. L. Warren. 2000. Development of a comorbidity index using physician claims data. J. Clin. Epidemiol. 53:12581267.
  • 25
    Berry, J., K. Bumpers, V. Ogunlade, R. Glover, S. Davis, M. Counts-Spriggs, et al. 2009. Examining racial disparities in colorectal cancer care. J. Psychosoc. Oncol. 27:5983.